Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. (Q46015851)
scientific article published on 11 May 2009
Language:
Current Data About Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin.
(P31) (Q13442814)
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

(P304) 257-260
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

(P407) (Q1860)

(P433) 2
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

(P478) 114
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

(P577) Monday, May 11, 2009
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

(P921) (Q421862)
(P887)

(Q29496)
(P887)

(Q264118)
(P887)

(Q55779816)
(P887)

(P1433) (Q885070)
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

(P1476) "Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin." (language: en)
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

(P2093) Sarit Assouline
(P1545) 1
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

Biljana Culjkovic
(P1545) 2
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

Eftihia Cocolakis
(P1545) 3
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

Caroline Rousseau
(P1545) 4
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

Nathalie Beslu
(P1545) 5
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

Abdellatif Amri
(P1545) 6
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

Stephen Caplan
(P1545) 7
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

Brian Leber
(P1545) 8
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

Denis-Claude Roy
(P1545) 9
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

Wilson H Miller
(P1545) 10
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

Katherine L B Borden
(P1545) 11
(P248)
(P698) 19433856
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/19433856

other details
description scientific article published on 11 May 2009

External Links
(P356) 10.1182/BLOOD-2009-02-205153
(P698) 19433856
(P5875) 24419339